WAIKOLOA, Hawaii — Just past the 15-year anniversary of the cefuroxime ESCRS trial, debate regarding antibiotic prophylaxis for endophthalmitis after cataract surgery continues.
“When you have something controversial, it's nice to see what our colleagues are doing,” David F. Chang, MD, said at Hawaiian Eye 2022.
To that end, surveys of ASCRS members conducted in 2007, 2014 and 2021 published in the Journal of Cataract and Refractive Surgery compare trends in endophthalmitis prophylaxis over time. In the latest survey, of approximately 1,200 respondents, 76% were from the U.S.